JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|6|824-833

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.6, 2015-06, pp. : 824-833

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Laboratory Significance of Defective P2Y12 Pathway Function in Patients with Myeloproliferative Neoplasms: A Pilot Study

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-06 ,pp. : 181-187

Karger

Access to resources Recommend Favorite

JAK2 and MPL Mutations in Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-06 ,pp. : 311-315

Karger

Access to resources Recommend Favorite

Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite